UK markets closed

Inovio Pharmaceuticals, Inc. (INO)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
21.88+1.56 (+7.70%)
As of 2:52PM EDT. Market open.
Full screen
Trade prices are not sourced from all markets
Previous close20.32
Open20.24
Bid21.86 x 800
Ask21.87 x 800
Day's range19.82 - 22.13
52-week range1.92 - 33.79
Volume13,971,903
Avg. volume35,713,756
Market cap3.459B
Beta (5Y monthly)1.46
PE ratio (TTM)N/A
EPS (TTM)-1.16
Earnings date10 Aug 2020
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est22.33
  • 3 Most Popular Coronavirus Stocks on Robinhood: Are They Buys?
    Motley Fool

    3 Most Popular Coronavirus Stocks on Robinhood: Are They Buys?

    Robinhood investors like two fast-growing biotechs and one big pharma company that each have promising COVID-19 vaccine candidates.

  • Better Coronavirus Stock: Inovio Pharmaceuticals or VBI Vaccines?
    Motley Fool

    Better Coronavirus Stock: Inovio Pharmaceuticals or VBI Vaccines?

    Inovio Pharmaceuticals (NASDAQ: INO) is enjoying its best stock performance in seven years thanks to investors' interest in its novel coronavirus vaccine program. VBI Vaccines (NASDAQ: VBIV) appears to be on track for its best year ever -- for the same reason. There are currently 25 COVID-19 vaccine candidates in clinical testing across the world.

  • Better Coronavirus Stock: Pfizer or Inovio Pharmaceuticals?
    Motley Fool

    Better Coronavirus Stock: Pfizer or Inovio Pharmaceuticals?

    There are no signs the coronavirus pandemic is slowing down in the U.S., with more than 1,100 Americans dying every day from COVID-19 in recent days. Beyond the staggering fatalities, one estimate by the Australian National University puts the virus' potential global economic damage at over $21 trillion. The need for a coronavirus vaccine has thus become paramount to saving lives and mitigating economic catastrophes.

By using Yahoo, you agree that we and our partners can use cookies for purposes such as customising content and advertising. See our Privacy Policy to learn more